vTv Therapeutics Q1 2026 Earnings Strong EPS Surprise Driven by NonOperating Items Stock Declines Acrivon Therapeutics Q1 2026 Earnings Narrowerthanexpected loss as clinical development progresses ZM Q1 2026 Earnings EPS Beat Drives 9 Stock Surge as Revenue Details Remain Unclear RPC Inc RES Q1 2026 Earnings EPS Surpasses Estimates Amid Disappointing Revenue Details and Stock Decline INTA Q1 2026 Earnings EPS Edges Past Estimates Amid Mixed Market Reaction YALA Q1 2026 Earnings Positive EPS of 016 Drives Modest Share Uptick